These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 13863628

  • 1. [Action on behavior of the combination of tranylcypromine and reserpine].
    BABBINI M, RICCIONI ML, MISSERE G, TONINI G.
    Arch Ital Sci Farmacol; 1961 Oct; 11():310-2. PubMed ID: 13863628
    [No Abstract] [Full Text] [Related]

  • 2. Further studies with tranylcypromine (monamine oxidase inhibitor) and its interaction with reserpine in rat brain.
    GREEN H, ERICKSON RW.
    Arch Int Pharmacodyn Ther; 1962 Feb 01; 135():407-25. PubMed ID: 13901404
    [No Abstract] [Full Text] [Related]

  • 3. [Characteristic changes of behavior induced by tranylcypromine].
    BABBINI M, RICCIONI ML, TONINI G.
    Arch Ital Sci Farmacol; 1961 Oct 01; 11():312-3. PubMed ID: 13863630
    [No Abstract] [Full Text] [Related]

  • 4. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
    GREEN H, SAWYER JL.
    J Pharmacol Exp Ther; 1960 Jul 01; 129():243-9. PubMed ID: 13851489
    [No Abstract] [Full Text] [Related]

  • 5. MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS IN ENHANCING AMPHETAMINE TOXICITY.
    BRITTAIN RT, JACK D, SPENCER PS.
    J Pharm Pharmacol; 1964 Aug 01; 16():565-7. PubMed ID: 14223999
    [No Abstract] [Full Text] [Related]

  • 6. The effect of reserpine and monoamine oxidase inhibitors on paradoxical sleep in the monkey.
    Reite M, Pegram GV, Stephens LM, Bixler EC, Lewis OL.
    Psychopharmacologia; 1969 Aug 01; 14(1):12-7. PubMed ID: 4310917
    [No Abstract] [Full Text] [Related]

  • 7. Action of reserpine and monoamine oxidase inhibitors on the urinary excretion of catecholamines in the rat.
    BICKEL MH, CARPI A, BOVET D.
    Helv Physiol Pharmacol Acta; 1961 Aug 01; 19():279-84. PubMed ID: 13868969
    [No Abstract] [Full Text] [Related]

  • 8. Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors.
    Greeff K, Dènes B, Tawfik H.
    Mod Probl Pharmacopsychiatry; 1983 Aug 01; 19():220-30. PubMed ID: 6408408
    [No Abstract] [Full Text] [Related]

  • 9. [The effect of monoamine oxidase inhibitors and reserpine on the gamma-aminobutyric acid content of the rat brain].
    Popov N, Matthies HJ.
    Acta Biol Med Ger; 1967 Aug 01; 18(1):91-8. PubMed ID: 5587220
    [No Abstract] [Full Text] [Related]

  • 10. Attempted correlations between behavioural and biochemical changes in rats following reserpine and chronic administration of amine-oxidase inhibitors.
    ACHESON RM, COLE J, DEARNALEY DP, DEARNALEY EJ.
    Psychopharmacologia; 1961 Aug 01; 2():277-94. PubMed ID: 13681211
    [No Abstract] [Full Text] [Related]

  • 11. Effect of reserpine on body temperature in the rat after pretreatment with amphetamine and monoamineoxidase inhibitors.
    Cremades A, Serrano JS, Jané F, Milanés MV.
    Methods Find Exp Clin Pharmacol; 1982 Aug 01; 4(8):563-8. PubMed ID: 7169843
    [Abstract] [Full Text] [Related]

  • 12. [Central effects of cocaine homologues and their modification by reserpine and adrenolytics].
    SCHMIDT G, MEISSE P.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1962 Aug 01; 243():148-61. PubMed ID: 14498710
    [No Abstract] [Full Text] [Related]

  • 13. THE EFFECTS OF RESERPINE ON THE SPONTANEOUS CONTRACTION OF THE ISOLATED ATRIUM OF RABBIT TREATED WITH MONOAMINE OXIDASE INHIBITORS.
    TACHI S, NAKATANI G, FUJIWARA M.
    Jpn J Pharmacol; 1963 Apr 01; 13():74-81. PubMed ID: 14065387
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N, Matthies H.
    Acta Biol Med Ger; 1966 Apr 01; 17(5):637-43. PubMed ID: 5991588
    [No Abstract] [Full Text] [Related]

  • 15. [Method for the determination of monoamine oxidase inhibitors].
    MAZZUCCHELLI L.
    Boll Chim Farm; 1962 Jun 01; 101():477-80. PubMed ID: 13934281
    [No Abstract] [Full Text] [Related]

  • 16. [On the relation between the mechanism of action of several psychotropic substances and the cerebral levels of biogenic amines of their precursors].
    LEVY J, MICHEL-BER E.
    Encephale; 1962 Jun 01; 51():132-48. PubMed ID: 14464771
    [No Abstract] [Full Text] [Related]

  • 17. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG, Baker RG, Banna NR.
    J Pharmacol Exp Ther; 1967 Dec 01; 158(3):405-15. PubMed ID: 5299660
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacologic effects of 2-phenylcycloalkylamines.
    McGrath WR, Kuhn WL.
    Arch Int Pharmacodyn Ther; 1968 Apr 01; 172(2):405-13. PubMed ID: 5684251
    [No Abstract] [Full Text] [Related]

  • 19. Tranylcypromine: a potent insulin secretagogue and hypoglycemic agent.
    Bressler R, Vargas-Cord M, Lebovitz HE.
    Diabetes; 1968 Oct 01; 17(10):617-24. PubMed ID: 4878653
    [No Abstract] [Full Text] [Related]

  • 20. Effect of monoamine oxidase inhibitors on rat paw edema induced by various phlogistic agents.
    Fekete M, Kürti AM.
    Eur J Pharmacol; 1970 May 01; 10(2):268-76. PubMed ID: 5446380
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.